We report a case of subconjunctival invasion of Dirofi laria repens in a woman from Southern Bulgaria. Dirofi lariasis is an extremely rare parasitic disease for Bulgaria. It occurs as an endemic parasitosis in the Mediterranean countries. It is caused by helminths of the genus Dirofi laria, which are parasites in dogs, cats, foxes, wolves -the fi nal hosts of the parasite. It may very rarely occur in humans, the infection triggered by a bite of bloodsucking mosquitoes, which are the intermediate hosts of Dirofi laria. The clinical forms of dirofi lariasis in humans are subcutaneous, pulmonary and ocular, the brain, testes and mammary glands being rarely aff ected. A 51-year-old patient presented with migrating edema in the area of the left temple and upper eyelid, with redness and swelling of the conjunctiva, as well as a subjective sense of movement under the eyelid of the left eye, lasting for about ten days. The subconjunctival localization of a moving 9.5-cm nematode was established, it was surgically removed and histologically studied. This case of ocular subconjunctival dirofi lariasis is of clinical interest due to the rarely observed pathology.
INTRODUCTION
Dirofi lariasis is a widespread zoonosis which occurs in temperate, tropical, and subtropical countries. 3 Adult females are usually 100-170 mm long by 4.6-6.5 mm wide. Males are smaller (50-70 mm long by 3.7-4.5 mm wide) (Fig. 1) . Species identifi cation of Dirofi lariae is based on morphological characteristics of the helminth cross-section. Dirofi laria repens is characterized by external longitudinal ridges, a thick laminated cuticle, thick muscle layer, and the diameter and laterals cords (Figs 2, 3) .
Dirofi laria repens is ovoviviparous and produces live microfi lariae (300-360 microns long by 6-8 microns wide). The blood of infected animals is full of circulating microfi lariae invading the intermediate host by bloodsucking. In the Malpighian tubules of the mosquito, microfi lariae moult until they reach an infective larval stage, which depends on the surrounding conditions (ambient temperature and humidity), and then migrate to the mouth of the mosquito.
When an infected mosquito bites, the infectious larvae fall under the skin of the fi nal host (animals), migrate and reach maturity; mature females emit live microfi lariae which circulate in the bloodstream. 4 Humans are accidental hosts of dirofi lariae. After a
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human gets bitten, microfi lariae usually die in the subcutaneous tissue, and it is on very rare occasions that surviving larvae develop into immature adult forms, reproductively inactive and unable to produce new microfi lariae, i.e. the infection is not contagious in humans. The incubation period lasts 27 to 34 weeks. Adult forms live in their hosts for several years. [5] [6] [7] In the eye, dirofi lariae can be found subconjunctivally, in Tenon's capsule, in the periorbital tissues (eyelids, orbit) and intraocularly -in the anterior chamber and the vitreous. [5] [6] [7] Microfi lariae enter the vitreous and the anterior chamber through the bloodstream, and adult forms can be found subcutaneously in the eyelids, the orbit or under the conjunctiva during the parasite's migration.
This case of subconjunctival dirofi lariasis presents a woman aged 51, a seamstress, whose complaints started on July 2, 2015, with the occurrence of edema in the area of the left temple, which subsequently moved to the area of the upper eyelid. After treatment with tobramycin/dexamethasone, the eyelid swelling subsided only to be replaced by irritation, redness and foreign body sensation in the left eye. The patient denied traumas, bites or any trips abroad. She has got a dog, which she keeps in the yard.
A comprehensive eye examination was performed, which established normal visual acuity and IOP of both eyes. Biomicroscopy exposed a moving white parasite in the left eye, located subconjunctivally, temporally (Fig. 4) . No pathological changes in the fundus of either eye were established. All blood indicators were within the reference range. Tests for fi larial antibody and microfi laremia were negative. After a consultation with an internist and a cardiologist, concomitant arterial hypertension and ischemic heart disease were diagnosed.
The parasite was carefully removed with two tweezers, through a small conjunctival incision, under local anaesthesia (epibulbar solution of proxymetacaine hydrochloride and 2% lidocaine hydrochloride subconjunctivally), after which it was sent for a morphological and parasitological examination. Macroscopically, the parasite was seen in motion, white in colour, 9.5 cm long and about 0.4 cm wide (Fig. 5) . Histopathological section of the worm showed thick cuticle with external longitudinal cuticular ridges and a thick muscle layer. Based on the morphologic features, the worm was identifi ed as Dirofi laria repens.
Postoperatively, topical treatment with tobramycin/dexamethasone eye drops and ointment, methylprednisolone acetate 40 mg intravenously for 3 days and desloratadine 1 tablet daily were applied.
A year later, the patient had subjective complains of dryness and discomfort in both eyes, which she associated with epidemic keratoconjunctivitis she suffered for several months after the removal of the parasite, as well as of an increased incidence of leg edema. After the conducted tests, we established normal visual acuity of both eyes, old corneal nummular nubeculae, a calm conjunctiva and fundi without any pathological changes; the complete blood count and the blood differential test showed values within the reference range; no eosinophilia was found; during the parasitological examination of a thick drop of blood, no microfi lariae were found; the abdominal ultrasound scan showed no abnormalities.
A consultation with a dermatologist was done fi nding no skin lesions. After the examination with a vascular surgeon, chronic venous insuffi ciency was established as the cause of the leg edema. The patient was discharged without any topical eye therapy.
DISCUSSION
The spread of dirofi lariasis depends on the presence of vector mosquitoes. Their development and survival is directly related to the favourable climatic conditions. 3 This parasitosis occurs in temperate, tropical and subtropical countries. By 2001, dirofi lariasis was mainly found in Southern Europe -in countries like Spain, Portugal, Italy, France 8 , Greece and Turkey. As of 2011, the data shows that the disease has been spreading across Eastern and Central Europe.
The largest number of cases have been described in Italy, followed by France, Greece and Spain. Although dirofi lariasis is considered endemic in these countries, reports have been published from many parts of the world like Africa, Australia, America, Europe 9,10 and Asia. There are reported cases of ocular dirofi lariasis in Serbia 11 , Denmark, Russia, Tunisia and Greece 5 . Within the last 6-7 years, cases of ocular dirofi lariasis have also been described in India, which is considered a non-endemic country. 5, 12 Of all the reported cases of ocular dirofi lariasis, the subconjunctival localization (60%) is most common, followed by eyelid and orbital dirofi lariasis (about 25%). 5 A case of dirofi lariasis in the anterior chamber has been reported by Chopra et al. in India. 12 Kalogeropoulos et al. published a series of 8 cases, two of which are of dirofi lariasis with localization in the vitreous, one in the orbit and 5 subconjunctivally. 5 The ocular symptoms are manifested by discomfort, eye pain and redness. In some reports, conjunctival dirofi lariasis is misdiagnosed as allergic conjunctivitis. The orbit and eyelid forms are less common, being manifested with edema and hyperemia of the eyelids, rarely with exophthalmos and diplopia; when localized in the vitreous, dirofi lariasis develops clinically as uveitis (uveoretinitis, neurouveitis).
The treatment involves surgical removal of the parasite. When localized subconjunctivally, after local anesthesia and an incision of the conjunctiva, the whole parasite is carefully removed in order to prevent an allergic reaction to parasitic residues. Intraocular Dirofi laria is removed through vitrectomy. No specifi c subsequent anthelmintic treatment is necessary, since D. repens is non-reproductive in humans, no microfi lariae are produced, and the removal of the adult parasite is suffi cient etiological treatment.
In order to establish a diagnosis, the parasitological and morphological study of the parasite matters as well. Of the blood indicators, eosinophilia causes suspicion -it occurs in less than 15% of the cases with D. immitis and rarely with D. repens. Blood smears (the microscopy of a thick drop of blood) to detect microfi lariae are usually negative.
Dirofi lariasis is a rare parasitosis for Bulgaria. D. repens is a parasite endemic to the Mediterranean countries. The transmission of the fi larial worms is dependent on the availability of microfi lariaemic hosts, competent mosquito vectors and suitable temperatures for the development of the infectious stages in the mosquito (L3). The extrinsic development to the infectious third larval stage takes about 10-12 days at 24-26°C but as long as 29 days at 18°C. Successful transmission of fi lariae to a host requires an infected mosquito to survive longer than the duration of the extrinsic incubation period. The maximal life span of mosquitos is 30 days. Climate change, the increasing average annual temperatures, the occurrence of favourable factors for the development and activity of vector mosquitoes, as well as trips to endemic countries, have led to the spread of the parasitosis to more geographical regions. Humans are accidental hosts to the parasite, and despite its rare ocular localization, dirofi lariasis has to be included in the differential diagnostic plan of eye diseases.
